Citadel Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-36,100
| Closed | -$314K | – | 15317 |
|
|
2021
Q3 | $314K | Buy |
+36,100
| New | +$329K | ﹤0.01% | 10979 |
|
|
2021
Q1 | – | Sell |
-10,700
| Closed | -$97K | – | 13941 |
|
|
2020
Q4 | $97K | Buy |
+10,700
| New | +$82.8K | ﹤0.01% | 10244 |
|
|
2020
Q2 | – | Sell |
-18,700
| Closed | -$136K | – | 10759 |
|
|
2020
Q1 | $136K | Buy |
18,700
+3,200
| +21% | +$23.7K | ﹤0.01% | 8384 |
|
|
2019
Q4 | $137K | Buy |
+15,500
| New | +$116K | ﹤0.01% | 8412 |
|
|
2019
Q3 | – | Sell |
-32,800
| Closed | -$137K | – | 9975 |
|
|
2019
Q2 | $137K | Sell |
32,800
-14,900
| -31% | -$78.6K | ﹤0.01% | 8402 |
|
|
2019
Q1 | $300K | Buy |
47,700
+24,900
| +109% | +$174K | ﹤0.01% | 7613 |
|
|
2018
Q4 | $148K | Sell |
22,800
-23,500
| -51% | -$180K | ﹤0.01% | 8066 |
|
|
2018
Q3 | $384K | Buy |
46,300
+18,300
| +65% | +$139K | ﹤0.01% | 7151 |
|
|
2018
Q2 | $174K | Sell |
28,000
-96,800
| -78% | -$616K | ﹤0.01% | 7991 |
|
|
2018
Q1 | $855K | Sell |
124,800
-50,000
| -29% | -$318K | ﹤0.01% | 5041 |
|
|
2017
Q4 | $1.15M | Buy |
174,800
+137,300
| +366% | +$839K | ﹤0.01% | 4459 |
|
|
2017
Q3 | $209K | Buy |
37,500
+26,500
| +241% | +$179K | ﹤0.01% | 6635 |
|
|
2017
Q2 | $85K | Sell |
11,000
-700
| -6% | -$5.92K | ﹤0.01% | 6964 |
|
|
2017
Q1 | $105K | Buy |
+11,700
| New | +$122K | ﹤0.01% | 6844 |
|
|
2016
Q4 | – | Sell |
-14,300
| Closed | -$234K | – | 8053 |
|
|
2016
Q3 | $234K | Buy |
+14,300
| New | +$201K | ﹤0.01% | 6084 |
|
|
2016
Q2 | – | Sell |
-29,900
| Closed | -$420K | – | 7591 |
|
|
2016
Q1 | $420K | Buy |
29,900
+26,200
| +708% | +$271K | ﹤0.01% | 4644 |
|
|
2015
Q4 | $40K | Buy |
3,700
+2,500
| +208% | +$22.6K | ﹤0.01% | 7483 |
|
|
2015
Q3 | $8K | Sell |
1,200
-6,200
| -84% | -$48K | ﹤0.01% | 8543 |
|
|
2015
Q2 | $68K | Buy |
+7,400
| New | +$56.1K | ﹤0.01% | 7437 |
|
Other funds holding NPTN
Citadel Advisors's NPTN Position: Q3 2022 in Review
Citadel Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 260,595 shares — an estimated $4.1M sold.
Citadel Advisors first reported a position in NPTN in Q2 2014 and held it in 29 quarters. The position peaked at $6.88M in Q1 2016. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Citadel Advisors reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Citadel Advisors sold 260,595 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.1M.
- Citadel Advisors first reported a position in NEOPHOTONICS CORP in Q2 2014 and held it in 29 quarters.
- Citadel Advisors's NEOPHOTONICS CORP position peaked at $6.88M in Q1 2016.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.